COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,572 Articles (22,415 medRxiv, 8,157 bioRxiv)

Most recent first Previous |  Page 854: Articles 8531-8540  | Next

Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
Allen, H., Tessier, E., Turner, C., Anderson, C., Blomquist, P., Simons, D., Lochen, A., Jarvis, C. I., Groves, N., Capelastegui, F., Flannagan, J., Zaidi, A., Chen, C., Rawlinson, C., Hughes, G. J., Chudasama, D., Nash, S., Thelwall, S., Lopez-Bernal, J., Dabrera, G., Charlett, A., Kall, M., Lamagni, T.
10.1101/2022.02.15.22271001 — Posted: 2022-02-17
Experimental infection of mink with SARS-COV-2 Omicron (BA.1) variant leads to symptomatic disease with lung pathology and transmission
Virtanen, J., Aaltonen, K., Kegler, K., Venkat, V., Niamsap, T., Kareinen, L., Malmgren, R., Kivela, O., Atanasova, N., Osterlund, P., Smura, T., Sukura, A., Strandin, T., Dutra, L., Vapalahti, O., Nordgren, H., Kant, R., Sironen, T.
10.1101/2022.02.16.480524 — Posted: 2022-02-16
Mathematical model of a cytokine storm
Kareva, I., Berezovskaya, F., Karev, G.
10.1101/2022.02.15.480585 — Posted: 2022-02-16
A possible way to relate the effects of SARS-CoV-2 induced changes in transferrin to severe COVID-19 associated diseases
Telek, E., Ujfalusi, Z., Kemenesi, G., Zana, B., Jakab, F., Lukacs, A., Hild, G.
10.1101/2022.02.15.480603 — Posted: 2022-02-16
Meta-analyses on SARS-CoV-2 Viral Titers in Wastewater and Their Correlations to Epidemiological Indicators
Mantilla-Calderon, D., Huang, K., Li, A., Chibwe, K., Yu, X., Ye, Y., Liu, L., Ling, F.
10.1101/2022.02.14.22270937 — Posted: 2022-02-16
City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants
Brunner, F. S., Brown, M. R., Bassano, I., Denise, H., Khalifa, M. S., Wade, M., Kevill, J. L., Jones, D. L., Farkas, K., Jeffries, A. R., The COVID-19 Genomics UK (COG-UK) Consortium, , Cairns, E., Wierzbicki, C., Paterson, S.
10.1101/2022.02.16.22269810 — Posted: 2022-02-16
SARS-CoV-2 Omicron BA.2 Variant Evades Neutralization by Therapeutic Monoclonal Antibodies
Zhou, H., Tada, T., Dcosta, B. M., Landau, N. R.
10.1101/2022.02.15.480166 — Posted: 2022-02-16 Discussion: Onsite
SARS-CoV-2 variants show a gradual declining pathogenicity and pro-inflammatory cytokine stimulation and an increasing antigenic and anti-inflammatory cytokine induction
Barh, D., Tiwari, S., Gomes, L. G. R., Pinto, C. H. R., Andrade, B., Ahmad, S., Aljabali, A. A. A., Alzahrani, K. J., Banjer, H. J., Hassan, S. S., Tambuwala, M., Redwan, E. M., Raza, K., Azevedo, V., Lundstrom, K., Uversky, V. N.
10.1101/2022.02.15.480592 — Posted: 2022-02-16
Non-productive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immunity responses
Kazmierski, J., Friedmann, K., Postmus, D., Fischer, C., Jansen, J., Richter, A., Bosquillon de Jarcy, L., Schüler, C., Sohn, M., Sauer, S., Drosten, C., Saliba, A.-E., Sander, L., Niemeyer, D., Goffinet, C.
10.1101/2022.02.15.480527 — Posted: 2022-02-16
Distinguishing Admissions Specifically for COVID-19 from Incidental SARS-CoV-2 Admissions: A National EHR Research Consortium Study
Klann, J. G., Strasser, Z. H., Hutch, M. R., Kennedy, C. J., Marwaha, J. S., Morris, M., Samayamuthu, M. J., Pfaff, A. C., Estiri, H., South, A. M., Weber, G. M., Yuan, W., Avillach, P., Wagholikar, K. B., Luo, Y., The Consortium for Clinical Characterization of COVID-19 by EHR (4CE), , Omenn, G. S., Visweswaran, S., Holmes, J. H., Xia, Z., Brat, G. A., Murphy, S. N.
10.1101/2022.02.10.22270728 — Posted: 2022-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).